2016's Worst Clinical Failures

It's been a rough year for drugmakers, but late clinical-stage failures made it especially tough ...

3 Dividend Stocks for Retirees

Here are a few good reasons why ExxonMobil, Bristol-Myers Squibb, and Microsoft would make smart ...